References
Della Pepa R, Picardi M, Sorà F et al (2016) Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry. Support Care Cancer 24(9):3839–3845
de Pauw BE, Raemaekers JM, Donnelly JP, Kullberg BJ, Meis JF (1995) An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. Ann Hematol 70(2):83–87
Kauffman CA, Bradley SF, Ross SC, Weber DR (1991) Hepatosplenic candidiasis: successful treatment with fluconazole. Am J Med 91(2):137–141
Anaissie E, Bodey GP, Kantarjian H et al (1991) Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 91(2):142–150
Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP (2000) Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis. Infect Dis Clin N Am 14(3):721–739
Nace HL, Horn D, Neofytos D (2009) Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007. Diagn Microbiol Infect Dis 64(3):289–294
Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN (2007) Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 59(4):401–406
Pulimood S, Ganesan L, Alangaden G, Chandrasekar P (2002) Polymicrobial candidemia. Diagn Microbiol Infect Dis 44(4):353–357
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Rights and permissions
About this article
Cite this article
Rolston, K. Letter to the editor—chronic disseminated candidiasis. Support Care Cancer 25, 1043–1044 (2017). https://doi.org/10.1007/s00520-016-3546-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3546-y